Status:
UNKNOWN
Personalized Smoking Cessation Infographic in COPD
Lead Sponsor:
Unity Health Toronto
Conditions:
Chronic Obstructive Pulmonary Disease (COPD)
Smoking Cessation
Eligibility:
All Genders
18+ years
Brief Summary
This study assesses the effect of a personalized smoking cessation infographic on physician smoking cessation counseling rates and smoking cessation pharmacotherapy prescription rates. The study asses...
Detailed Description
Chronic obstructive pulmonary disease (COPD) affects 11.8% of adult Ontarians, remains the leading cause of hospitalization in Canada, and cost the Canadian economy $770 million in 2010. Smoking cessa...
Eligibility Criteria
Inclusion
- Eligible clinicians will include respirologists, general practitioners and nurse practitioners who refer patients for spirometry testing at the St. Michael's Hospital Pulmonary Function Lab.
Exclusion
Key Trial Info
Start Date :
January 9 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04119934
Start Date
January 9 2023
End Date
July 1 2024
Last Update
February 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Michael's Hospital
Toronto, Ontario, Canada, M5B 1W8